338 related articles for article (PubMed ID: 23636127)
21. Inhibition of STAT3 promotes the efficacy of adoptive transfer therapy using type-1 CTLs by modulation of the immunological microenvironment in a murine intracranial glioma.
Fujita M; Zhu X; Sasaki K; Ueda R; Low KL; Pollack IF; Okada H
J Immunol; 2008 Feb; 180(4):2089-98. PubMed ID: 18250414
[TBL] [Abstract][Full Text] [Related]
22. Extracellular vesicles derived from hypoxic glioma stem-like cells confer temozolomide resistance on glioblastoma by delivering miR-30b-3p.
Yin J; Ge X; Shi Z; Yu C; Lu C; Wei Y; Zeng A; Wang X; Yan W; Zhang J; You Y
Theranostics; 2021; 11(4):1763-1779. PubMed ID: 33408780
[No Abstract] [Full Text] [Related]
23. MicroRNA-130b promotes cell proliferation and invasion by inhibiting peroxisome proliferator-activated receptor-γ in human glioma cells.
Gu JJ; Zhang JH; Chen HJ; Wang SS
Int J Mol Med; 2016 Jun; 37(6):1587-93. PubMed ID: 27122306
[TBL] [Abstract][Full Text] [Related]
24. The MicroRNA-106a/20b Strongly Enhances the Antitumour Immune Responses of Dendritic Cells Pulsed with Glioma Stem Cells by Targeting STAT3.
Zhou H; Sun C; Li C; Hua S; Li F; Li R; Cai D; Zou Y; Cai Y; Jiang X
J Immunol Res; 2022; 2022():9721028. PubMed ID: 36157880
[TBL] [Abstract][Full Text] [Related]
25. miR-139 Functions as An Antioncomir to Repress Glioma Progression Through Targeting IGF-1 R, AMY-1, and PGC-1β.
Wang H; Yan X; Ji LY; Ji XT; Wang P; Guo SW; Li SZ
Technol Cancer Res Treat; 2017 Aug; 16(4):497-511. PubMed ID: 26868851
[TBL] [Abstract][Full Text] [Related]
26. Role of STAT3 in CD4+CD25+FOXP3+ regulatory lymphocyte generation: implications in graft-versus-host disease and antitumor immunity.
Pallandre JR; Brillard E; Créhange G; Radlovic A; Remy-Martin JP; Saas P; Rohrlich PS; Pivot X; Ling X; Tiberghien P; Borg C
J Immunol; 2007 Dec; 179(11):7593-604. PubMed ID: 18025205
[TBL] [Abstract][Full Text] [Related]
27. Effect of miR-142-3p on the M2 macrophage and therapeutic efficacy against murine glioblastoma.
Xu S; Wei J; Wang F; Kong LY; Ling XY; Nduom E; Gabrusiewicz K; Doucette T; Yang Y; Yaghi NK; Fajt V; Levine JM; Qiao W; Li XG; Lang FF; Rao G; Fuller GN; Calin GA; Heimberger AB
J Natl Cancer Inst; 2014 Aug; 106(8):. PubMed ID: 24974128
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes.
Li Y; Guessous F; Zhang Y; Dipierro C; Kefas B; Johnson E; Marcinkiewicz L; Jiang J; Yang Y; Schmittgen TD; Lopes B; Schiff D; Purow B; Abounader R
Cancer Res; 2009 Oct; 69(19):7569-76. PubMed ID: 19773441
[TBL] [Abstract][Full Text] [Related]
29. NF-κB-driven miR-34a impairs Treg/Th17 balance via targeting Foxp3.
Xie M; Wang J; Gong W; Xu H; Pan X; Chen Y; Ru S; Wang H; Chen X; Zhao Y; Li J; Yin Q; Xia S; Zhou X; Liu X; Shao Q
J Autoimmun; 2019 Aug; 102():96-113. PubMed ID: 31130368
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-106b-5p boosts glioma tumorigensis by targeting multiple tumor suppressor genes.
Liu F; Gong J; Huang W; Wang Z; Wang M; Yang J; Wu C; Wu Z; Han B
Oncogene; 2014 Oct; 33(40):4813-22. PubMed ID: 24166509
[TBL] [Abstract][Full Text] [Related]
31. Blockage of a miR-21/EGFR regulatory feedback loop augments anti-EGFR therapy in glioblastomas.
Zhang KL; Han L; Chen LY; Shi ZD; Yang M; Ren Y; Chen LC; Zhang JX; Pu PY; Kang CS
Cancer Lett; 2014 Jan; 342(1):139-49. PubMed ID: 24012640
[TBL] [Abstract][Full Text] [Related]
32. Single-Cell RNA-Sequencing Shift in the Interaction Pattern Between Glioma Stem Cells and Immune Cells During Tumorigenesis.
Zhai Y; Li G; Li R; Chang Y; Feng Y; Wang D; Wu F; Zhang W
Front Immunol; 2020; 11():581209. PubMed ID: 33133100
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-30a suppresses self-renewal and tumorigenicity of glioma stem cells by blocking the NT5E-dependent Akt signaling pathway.
Peng L; Ming Y; Zhang L; Zhou J; Xiang W; Zeng S; He H; Chen L
FASEB J; 2020 Apr; 34(4):5128-5143. PubMed ID: 32067282
[TBL] [Abstract][Full Text] [Related]
34. Intratumoral mediated immunosuppression is prognostic in genetically engineered murine models of glioma and correlates to immunotherapeutic responses.
Kong LY; Wu AS; Doucette T; Wei J; Priebe W; Fuller GN; Qiao W; Sawaya R; Rao G; Heimberger AB
Clin Cancer Res; 2010 Dec; 16(23):5722-33. PubMed ID: 20921210
[TBL] [Abstract][Full Text] [Related]
35. Hypoxic BMSC-derived exosomal miRNAs promote metastasis of lung cancer cells via STAT3-induced EMT.
Zhang X; Sai B; Wang F; Wang L; Wang Y; Zheng L; Li G; Tang J; Xiang J
Mol Cancer; 2019 Mar; 18(1):40. PubMed ID: 30866952
[TBL] [Abstract][Full Text] [Related]
36. Regulation of the MIR155 host gene in physiological and pathological processes.
Elton TS; Selemon H; Elton SM; Parinandi NL
Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
[TBL] [Abstract][Full Text] [Related]
37. Involvement of FOS-mediated miR-181b/miR-21 signalling in the progression of malignant gliomas.
Tao T; Wang Y; Luo H; Yao L; Wang L; Wang J; Yan W; Zhang J; Wang H; Shi Y; Yin Y; Jiang T; Kang C; Liu N; You Y
Eur J Cancer; 2013 Sep; 49(14):3055-63. PubMed ID: 23810250
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-101 inhibits proliferation, migration and invasion of human glioblastoma by targeting SOX9.
Liu N; Zhang L; Wang Z; Cheng Y; Zhang P; Wang X; Wen W; Yang H; Liu H; Jin W; Zhang Y; Tu Y
Oncotarget; 2017 Mar; 8(12):19244-19254. PubMed ID: 27911279
[TBL] [Abstract][Full Text] [Related]
39. Dual PLK1 and STAT3 inhibition promotes glioblastoma cells apoptosis through MYC.
Wang H; Tao Z; Feng M; Li X; Deng Z; Zhao G; Yin H; Pan T; Chen G; Feng Z; Li Y; Zhou Y
Biochem Biophys Res Commun; 2020 Dec; 533(3):368-375. PubMed ID: 32962858
[TBL] [Abstract][Full Text] [Related]
40. miR-124 Acts as a Tumor Suppressor in Glioblastoma via the Inhibition of Signal Transducer and Activator of Transcription 3.
Li W; Huang H; Su J; Ji X; Zhang X; Zhang Z; Wang H
Mol Neurobiol; 2017 May; 54(4):2555-2561. PubMed ID: 26993295
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
